Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Curcumenol is a sesquiterpenoid compound and one of the major bioactive components of Zedoary turmeric oil (from Curcuma zedoaria and related Curcuma species)[1][2][9]. It has been reported to possess a range of biological activities including anti-inflammatory[1][2], neuroprotective[2][3], hepatoprotective[2], antibiotic/antibacterial (notably against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa)[9], and anticancer effects[7]. Mechanistically it inhibits NF-kappaB activation by suppressing nuclear translocation of the NF-kappaB p65 subunit and blocking IκBα phosphorylation/degradation; it also inhibits cytochrome P450 isoform CYP3A4 competitively in vitro but is not considered a mechanism-based inhibitor at clinically relevant concentrations[7]. Its main source is the rhizome of Curcuma zedoaria.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on curcumenol.